Drugs, Poisons and Controlled Substances (Drugs of Dependence - Synthetic Cannabinoids and Other Substances) Regulations 2015
Authorised by the Chief Parliamentary Counsel
Authorised Version
i
Drugs, Poisons and Controlled Substances (Drugs
of Dependence - Synthetic Cannabinoids and Other
Substances) Regulations 2015
S.R. No. 124/2015
TABLE OF PROVISIONS
Regulation Page
1 Objective 1
2 Authorising provision 1
3 Commencement 1
4 Revocation 2
5 Prescribed drugs of dependence 2
6 Expiry 3
═══════════════
Endnotes 4
-- 1 of 5 --
Authorised by the Chief Parliamentary Counsel
Authorised Version
1
STATUTORY RULES 2015
S.R. No. 124/2015
Drugs, Poisons and Controlled Substances Act 1981
Drugs, Poisons and Controlled Substances (Drugs
of Dependence - Synthetic Cannabinoids and Other
Substances) Regulations 2015
The Governor in Council makes the following Regulations:
Dated: 27th October 2015
Responsible Minister:
MARTIN FOLEY
Minister for Mental Health
MATTHEW McBEATH
Clerk of the Executive Council
1 Objective
The objective of these Regulations is to prescribe
synthetic cannabinoids as drugs of dependence for
the purposes of the Drugs, Poisons and
Controlled Substances Act 1981.
2 Authorising provision
These Regulations are made under section 132AA
of the Drugs, Poisons and Controlled
Substances Act 1981.
3 Commencement
These Regulations come into operation on
27 October 2015.
-- 2 of 5 --
Drugs, Poisons and Controlled Substances (Drugs of Dependence - Synthetic
Cannabinoids and Other Substances) Regulations 2015
S.R. No. 124/2015
2
Authorised by the Chief Parliamentary Counsel
4 Revocation
The Drugs, Poisons and Controlled Substances
(Drugs of Dependence - Synthetic Cannabinoids)
Regulations 2014 1 are revoked.
5 Prescribed drugs of dependence
For the purposes of paragraph (ba) of the
definition of drug of dependence in section 4(1)
of the Drugs, Poisons and Controlled
Substances Act 1981—
(a) a substance specified in Column 1 of the
Table to this regulation is a drug of
dependence included in Part 3 of
Schedule Eleven to that Act; and
(b) for the purposes of Part 3 of Schedule Eleven
to that Act, the specified quantities of that
drug for the purposes of Columns 1A to 4 of
that Part of that Schedule are the quantities
in Columns 1A to 4 of the Table to this
regulation in relation to that drug that
correspond to the relevant column of that
Part of that Schedule.
TABLE
Column 1
Drug
Column 1A
(Large
Commercial
Quantity)
Quantity
Column 1B
(Large
Commercial
Quantity)
Quantity of
mixture of
substance and
drug of
dependence
Column 2
(Commercial
Quantity)
Quantity
Column 2A
(Commercial
Quantity)
Quantity of
mixture of
substance and
drug of
dependence
Column 2B
(Automatic
Forfeiture
Quantity)
Quantity
Column 3
(Traffickable
Quantity)
Quantity of
mixture of
substance and
drug of
dependence
Column 3A
(Traffickable
Quantity)
Quantity
Column 4
(Small
Quantity)
Quantity
N-[1-(AMINOCARBONYL)-2-
METHYLPROPYL]-1-
PENTYLINDAZOLE-3-
CARBOXAMIDE (common
name AB-PINACA)
10·0 kg 1·0 kg 3·0 g 1·0 g
N-[1-(AMINOCARBONYL)-2-
METHYLPROPYL]-1-
(CYCLOHEXYLMETHYL)
INDAZOLE-3-CARBOXAMIDE
(common name
AB-CHMINACA)
10·0 kg 1·0 kg 3·0 g 1·0 g
-- 3 of 5 --
Drugs, Poisons and Controlled Substances (Drugs of Dependence - Synthetic
Cannabinoids and Other Substances) Regulations 2015
S.R. No. 124/2015
3
Authorised by the Chief Parliamentary Counsel
Column 1
Drug
Column 1A
(Large
Commercial
Quantity)
Quantity
Column 1B
(Large
Commercial
Quantity)
Quantity of
mixture of
substance and
drug of
dependence
Column 2
(Commercial
Quantity)
Quantity
Column 2A
(Commercial
Quantity)
Quantity of
mixture of
substance and
drug of
dependence
Column 2B
(Automatic
Forfeiture
Quantity)
Quantity
Column 3
(Traffickable
Quantity)
Quantity of
mixture of
substance and
drug of
dependence
Column 3A
(Traffickable
Quantity)
Quantity
Column 4
(Small
Quantity)
Quantity
N-[1-(METHOXYCARBONYL)-
2,2-DIMETHYLPROPYL]-1-
(CYCLOHEXYLMETHYL)
INDOLE-3-CARBOXAMIDE
(common name MMB-
CHMINACA)
10·0 kg 1·0 kg 3·0 g 1·0 g
N-[1-(AMINOCARBONYL)-2-
METHYLPROPYL]-1-[(4-
FLUOROPHENYL)
METHYL]-INDAZOLE-3-
CARBOXAMIDE (common
name AB-FUBINACA)
10·0 kg 1·0 kg 3·0 g 1·0 g
3,4-DICHLORO-N-([1-
(DIMETHYLAMINO)
CYCLOHEXYL]METHYL)
BENZAMIDE (common
name AH-7921)
750·0 g 1·0 kg 250·0 g 500·0 g 30·0 g 3·0 g 1·0 g
INDAZOLE-3-
CARBOXAMIDES whether or
not with any modification on the
indazole or amide nitrogens,
whether or not further modified
on the indazole ring
10·0 kg 1·0 kg 3·0 g 1·0 g
INDOLE-3-CARBOXAMIDES
with any modification on the
indole or amide nitrogens,
whether or not further modified
on the indole ring
10·0 kg 1·0 kg 3·0 g 1·0 g
N-[(1-AMINOCYCLOHEXYL)
METHYL]BENZAMIDES,
including those with any
modification on the amino-
and/or amido-nitrogens, whether
or not further modified on the
aromatic or cyclohexyl rings
750·0 g 1·0 kg 250·0 g 500·0 g 30·0 g 3·0 g 1·0 g
6 Expiry
These Regulations expire on 25 October 2016.
═══════════════
-- 4 of 5 --
Endnotes
Drugs, Poisons and Controlled Substances (Drugs of Dependence - Synthetic
Cannabinoids and Other Substances) Regulations 2015
S.R. No. 124/2015
4
Authorised by the Chief Parliamentary Counsel
Endnotes
1 Reg. 4: S.R. No. 195/2014.
-- 5 of 5 --